PROCEPT BioRobotics (PRCT) Change in Accured Expenses (2020 - 2026)

PROCEPT BioRobotics (PRCT) has reported Change in Accured Expenses for 7 consecutive years, with $2.0 million the latest figure, recorded in Q2 2026.

• On a quarterly basis, Change in Accured Expenses rose 49.43% year-over-year to $2.0 million in Q2 2026; TTM through Jun 2026 was $4.4 million, a 212.01% increase from a year earlier, with the FY2025 full-year figure at $1.9 million, down 59.85% from the prior year.
• Change in Accured Expenses was $2.0 million for Q2 2026 at PROCEPT BioRobotics, up from -$4.7 million in the prior quarter.
• Over five years, Change in Accured Expenses peaked at $5.5 million in Q3 2025 and troughed at -$6.6 million in Q1 2025.
• A 5-year average of $789111.1 and a median of $2.5 million in 2022 frame the typical range for Change in Accured Expenses.
• Across the five-year window, Change in Accured Expenses soared 473.25% in 2022 and slumped 219.69% in 2023, its largest moves.
• Over 5 years, Change in Accured Expenses stood at $3.2 million in 2022, then fell by 1.36% to $3.1 million in 2023, then declined by 13.34% to $2.7 million in 2024, then sank by 38.55% to $1.7 million in 2025, then climbed by 18.12% to $2.0 million in 2026.
• The last three Change in Accured Expenses figures came in at $2.0 million (Q2 2026), -$4.7 million (Q1 2026), and $1.7 million (Q4 2025), per Business Quant data.